NAMS vs PRQR: Side-by-Side Comparison
Compare NewAmsterdam Pharma Company NV (NAMS) and ProQR Therapeutics N.V (PRQR) side by side: market cap USD 4.07B vs USD 190.71M. Financials, growth and model signals on Bullrun.
| Metric | NAMS | PRQR |
|---|---|---|
| Company | NewAmsterdam Pharma Company NV | ProQR Therapeutics N.V |
| Country / Exchange | Netherlands · NASDAQ | Netherlands · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | USD 4.07B | USD 190.71M |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (latest FY) | USD 22.50M | — |
| Revenue growth YoY | -50.6% | — |
| Net income | USD -203.00M | — |
| Gross margin | — | — |
| Diluted EPS | -1.72 | — |